nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.293	0.418	CrCrCtD
Doxylamine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.263	0.376	CrCrCtD
Doxylamine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.144	0.206	CrCrCtD
Doxylamine—Toremifene—CYP1A2—type 2 diabetes mellitus	0.00026	0.0502	CrCbGaD
Doxylamine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00024	0.000923	CcSEcCtD
Doxylamine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00024	0.000922	CcSEcCtD
Doxylamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000239	0.00092	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000238	0.000918	CcSEcCtD
Doxylamine—Tremor—Metformin—type 2 diabetes mellitus	0.000238	0.000917	CcSEcCtD
Doxylamine—Sweating—Ramipril—type 2 diabetes mellitus	0.000238	0.000914	CcSEcCtD
Doxylamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000237	0.000914	CcSEcCtD
Doxylamine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000237	0.000912	CcSEcCtD
Doxylamine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000237	0.000912	CcSEcCtD
Doxylamine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000236	0.000908	CcSEcCtD
Doxylamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000235	0.000906	CcSEcCtD
Doxylamine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000234	0.000901	CcSEcCtD
Doxylamine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000232	0.000895	CcSEcCtD
Doxylamine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000232	0.000893	CcSEcCtD
Doxylamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000232	0.000892	CcSEcCtD
Doxylamine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000231	0.00089	CcSEcCtD
Doxylamine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000231	0.000888	CcSEcCtD
Doxylamine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00023	0.000884	CcSEcCtD
Doxylamine—Malaise—Metformin—type 2 diabetes mellitus	0.000229	0.000883	CcSEcCtD
Doxylamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000229	0.000882	CcSEcCtD
Doxylamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000228	0.000879	CcSEcCtD
Doxylamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000228	0.000878	CcSEcCtD
Doxylamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000228	0.000877	CcSEcCtD
Doxylamine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000228	0.000876	CcSEcCtD
Doxylamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000227	0.000875	CcSEcCtD
Doxylamine—Rash—Glipizide—type 2 diabetes mellitus	0.000226	0.000871	CcSEcCtD
Doxylamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000226	0.00087	CcSEcCtD
Doxylamine—Erythema—Losartan—type 2 diabetes mellitus	0.000226	0.000869	CcSEcCtD
Doxylamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000225	0.000867	CcSEcCtD
Doxylamine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000225	0.000865	CcSEcCtD
Doxylamine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000225	0.0434	CrCbGaD
Doxylamine—Palpitations—Metformin—type 2 diabetes mellitus	0.000225	0.000865	CcSEcCtD
Doxylamine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000224	0.000864	CcSEcCtD
Doxylamine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000223	0.00086	CcSEcCtD
Doxylamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000223	0.000859	CcSEcCtD
Doxylamine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000223	0.000857	CcSEcCtD
Doxylamine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000222	0.000856	CcSEcCtD
Doxylamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000221	0.000853	CcSEcCtD
Doxylamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000221	0.000851	CcSEcCtD
Doxylamine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000221	0.00085	CcSEcCtD
Doxylamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00085	CcSEcCtD
Doxylamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00022	0.000849	CcSEcCtD
Doxylamine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00022	0.000849	CcSEcCtD
Doxylamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000219	0.000845	CcSEcCtD
Doxylamine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000219	0.000844	CcSEcCtD
Doxylamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000218	0.000838	CcSEcCtD
Doxylamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000217	0.000836	CcSEcCtD
Doxylamine—Clemastine—CYP3A4—type 2 diabetes mellitus	0.000217	0.0419	CrCbGaD
Doxylamine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000217	0.000836	CcSEcCtD
Doxylamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000217	0.000835	CcSEcCtD
Doxylamine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000216	0.000833	CcSEcCtD
Doxylamine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000216	0.00083	CcSEcCtD
Doxylamine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000215	0.000827	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000214	0.000824	CcSEcCtD
Doxylamine—Discomfort—Metformin—type 2 diabetes mellitus	0.000214	0.000823	CcSEcCtD
Doxylamine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000214	0.000823	CcSEcCtD
Doxylamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000213	0.000821	CcSEcCtD
Doxylamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000213	0.00082	CcSEcCtD
Doxylamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000213	0.00082	CcSEcCtD
Doxylamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000212	0.000817	CcSEcCtD
Doxylamine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000212	0.000817	CcSEcCtD
Doxylamine—Tremor—Losartan—type 2 diabetes mellitus	0.000212	0.000814	CcSEcCtD
Doxylamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000211	0.000813	CcSEcCtD
Doxylamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000211	0.000812	CcSEcCtD
Doxylamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00081	CcSEcCtD
Doxylamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00081	CcSEcCtD
Doxylamine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00021	0.00081	CcSEcCtD
Doxylamine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00021	0.000807	CcSEcCtD
Doxylamine—Agitation—Losartan—type 2 diabetes mellitus	0.000208	0.000799	CcSEcCtD
Doxylamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000207	0.000796	CcSEcCtD
Doxylamine—Flushing—Ramipril—type 2 diabetes mellitus	0.000206	0.000795	CcSEcCtD
Doxylamine—Angioedema—Losartan—type 2 diabetes mellitus	0.000206	0.000794	CcSEcCtD
Doxylamine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000206	0.000793	CcSEcCtD
Doxylamine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000204	0.000787	CcSEcCtD
Doxylamine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000204	0.000784	CcSEcCtD
Doxylamine—Malaise—Losartan—type 2 diabetes mellitus	0.000204	0.000784	CcSEcCtD
Doxylamine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000204	0.000784	CcSEcCtD
Doxylamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000203	0.000783	CcSEcCtD
Doxylamine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000203	0.000783	CcSEcCtD
Doxylamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000203	0.000782	CcSEcCtD
Doxylamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000203	0.000782	CcSEcCtD
Doxylamine—Vertigo—Losartan—type 2 diabetes mellitus	0.000203	0.000781	CcSEcCtD
Doxylamine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000203	0.00078	CcSEcCtD
Doxylamine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000202	0.000778	CcSEcCtD
Doxylamine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000202	0.000777	CcSEcCtD
Doxylamine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000201	0.000773	CcSEcCtD
Doxylamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000201	0.000772	CcSEcCtD
Doxylamine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.000772	CcSEcCtD
Doxylamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0002	0.000769	CcSEcCtD
Doxylamine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.0002	0.000769	CcSEcCtD
Doxylamine—Palpitations—Losartan—type 2 diabetes mellitus	0.0002	0.000768	CcSEcCtD
Doxylamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000199	0.000766	CcSEcCtD
Doxylamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000198	0.000763	CcSEcCtD
Doxylamine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000198	0.000763	CcSEcCtD
Doxylamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000198	0.000763	CcSEcCtD
Doxylamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000198	0.000761	CcSEcCtD
Doxylamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000197	0.000759	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000197	0.000757	CcSEcCtD
Doxylamine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000196	0.000756	CcSEcCtD
Doxylamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000196	0.000754	CcSEcCtD
Doxylamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000196	0.000754	CcSEcCtD
Doxylamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000195	0.000752	CcSEcCtD
Doxylamine—Constipation—Valsartan—type 2 diabetes mellitus	0.000195	0.00075	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000194	0.000748	CcSEcCtD
Doxylamine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.000194	0.0375	CrCbGaD
Doxylamine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000194	0.000747	CcSEcCtD
Doxylamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000194	0.000746	CcSEcCtD
Doxylamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000194	0.000745	CcSEcCtD
Doxylamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00074	CcSEcCtD
Doxylamine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.000739	CcSEcCtD
Doxylamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000192	0.000738	CcSEcCtD
Doxylamine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000192	0.037	CrCbGaD
Doxylamine—Anxiety—Losartan—type 2 diabetes mellitus	0.000192	0.000738	CcSEcCtD
Doxylamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000191	0.000736	CcSEcCtD
Doxylamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000733	CcSEcCtD
Doxylamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000733	CcSEcCtD
Doxylamine—Discomfort—Losartan—type 2 diabetes mellitus	0.00019	0.000731	CcSEcCtD
Doxylamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000189	0.000729	CcSEcCtD
Doxylamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000189	0.000728	CcSEcCtD
Doxylamine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000188	0.000724	CcSEcCtD
Doxylamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000187	0.000719	CcSEcCtD
Doxylamine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000186	0.000717	CcSEcCtD
Doxylamine—Confusional state—Losartan—type 2 diabetes mellitus	0.000186	0.000715	CcSEcCtD
Doxylamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000186	0.000714	CcSEcCtD
Doxylamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000185	0.000712	CcSEcCtD
Doxylamine—Somnolence—Metformin—type 2 diabetes mellitus	0.000184	0.00071	CcSEcCtD
Doxylamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000184	0.000709	CcSEcCtD
Doxylamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000183	0.000704	CcSEcCtD
Doxylamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000183	0.000703	CcSEcCtD
Doxylamine—Tremor—Ramipril—type 2 diabetes mellitus	0.000181	0.000698	CcSEcCtD
Doxylamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000181	0.000697	CcSEcCtD
Doxylamine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000181	0.000696	CcSEcCtD
Doxylamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00018	0.000695	CcSEcCtD
Doxylamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00018	0.000694	CcSEcCtD
Doxylamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00018	0.000692	CcSEcCtD
Doxylamine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00018	0.000692	CcSEcCtD
Doxylamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000179	0.000691	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000179	0.00069	CcSEcCtD
Doxylamine—Fatigue—Metformin—type 2 diabetes mellitus	0.000179	0.000689	CcSEcCtD
Doxylamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000179	0.000689	CcSEcCtD
Doxylamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000178	0.000686	CcSEcCtD
Doxylamine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000178	0.000685	CcSEcCtD
Doxylamine—Agitation—Ramipril—type 2 diabetes mellitus	0.000178	0.000685	CcSEcCtD
Doxylamine—Constipation—Metformin—type 2 diabetes mellitus	0.000177	0.000683	CcSEcCtD
Doxylamine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000177	0.000681	CcSEcCtD
Doxylamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000176	0.000676	CcSEcCtD
Doxylamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000176	0.000676	CcSEcCtD
Doxylamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000175	0.000676	CcSEcCtD
Doxylamine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.000175	0.0338	CrCbGaD
Doxylamine—Malaise—Ramipril—type 2 diabetes mellitus	0.000175	0.000672	CcSEcCtD
Doxylamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000175	0.000672	CcSEcCtD
Doxylamine—Rash—Glyburide—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Doxylamine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Doxylamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Doxylamine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Doxylamine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000173	0.000667	CcSEcCtD
Doxylamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000172	0.000663	CcSEcCtD
Doxylamine—Toremifene—CYP3A4—type 2 diabetes mellitus	0.000172	0.0332	CrCbGaD
Doxylamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000171	0.000659	CcSEcCtD
Doxylamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000171	0.000658	CcSEcCtD
Doxylamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00017	0.000655	CcSEcCtD
Doxylamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00017	0.000653	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000169	0.000651	CcSEcCtD
Doxylamine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000169	0.00065	CcSEcCtD
Doxylamine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	0.000168	0.0325	CrCbGaD
Doxylamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000168	0.000646	CcSEcCtD
Doxylamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000168	0.000646	CcSEcCtD
Doxylamine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000167	0.000645	CcSEcCtD
Doxylamine—Insomnia—Losartan—type 2 diabetes mellitus	0.000167	0.000642	CcSEcCtD
Doxylamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000166	0.000639	CcSEcCtD
Doxylamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000165	0.000635	CcSEcCtD
Doxylamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000164	0.000633	CcSEcCtD
Doxylamine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000164	0.000632	CcSEcCtD
Doxylamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000164	0.000632	CcSEcCtD
Doxylamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000164	0.000631	CcSEcCtD
Doxylamine—Somnolence—Losartan—type 2 diabetes mellitus	0.000164	0.000631	CcSEcCtD
Doxylamine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000163	0.000629	CcSEcCtD
Doxylamine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000163	0.000627	CcSEcCtD
Doxylamine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000162	0.000622	CcSEcCtD
Doxylamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000161	0.000621	CcSEcCtD
Doxylamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000161	0.000621	CcSEcCtD
Doxylamine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000161	0.000621	CcSEcCtD
Doxylamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00016	0.000617	CcSEcCtD
Doxylamine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000159	0.000613	CcSEcCtD
Doxylamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000159	0.000613	CcSEcCtD
Doxylamine—Fatigue—Losartan—type 2 diabetes mellitus	0.000159	0.000612	CcSEcCtD
Doxylamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000158	0.000608	CcSEcCtD
Doxylamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000158	0.000607	CcSEcCtD
Doxylamine—Constipation—Losartan—type 2 diabetes mellitus	0.000158	0.000607	CcSEcCtD
Doxylamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000156	0.000602	CcSEcCtD
Doxylamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000156	0.000601	CcSEcCtD
Doxylamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000156	0.0006	CcSEcCtD
Doxylamine—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.000156	0.03	CrCbGaD
Doxylamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000156	0.000599	CcSEcCtD
Doxylamine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.000597	CcSEcCtD
Doxylamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000155	0.000596	CcSEcCtD
Doxylamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000154	0.000594	CcSEcCtD
Doxylamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000154	0.000593	CcSEcCtD
Doxylamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000153	0.000588	CcSEcCtD
Doxylamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000152	0.000585	CcSEcCtD
Doxylamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000151	0.00058	CcSEcCtD
Doxylamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000151	0.00058	CcSEcCtD
Doxylamine—Doxepin—ADRA2A—type 2 diabetes mellitus	0.000149	0.0288	CrCbGaD
Doxylamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000149	0.000573	CcSEcCtD
Doxylamine—Asthenia—Metformin—type 2 diabetes mellitus	0.000149	0.000573	CcSEcCtD
Doxylamine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	0.000149	0.0287	CrCbGaD
Doxylamine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000148	0.000568	CcSEcCtD
Doxylamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000147	0.000567	CcSEcCtD
Doxylamine—Pruritus—Metformin—type 2 diabetes mellitus	0.000147	0.000565	CcSEcCtD
Doxylamine—Urticaria—Losartan—type 2 diabetes mellitus	0.000146	0.000564	CcSEcCtD
Doxylamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000145	0.000558	CcSEcCtD
Doxylamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000144	0.000555	CcSEcCtD
Doxylamine—Rash—Valsartan—type 2 diabetes mellitus	0.000144	0.000553	CcSEcCtD
Doxylamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000144	0.000553	CcSEcCtD
Doxylamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000143	0.000551	CcSEcCtD
Doxylamine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000143	0.00055	CcSEcCtD
Doxylamine—Disopyramide—CYP3A4—type 2 diabetes mellitus	0.000143	0.0275	CrCbGaD
Doxylamine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000142	0.000547	CcSEcCtD
Doxylamine—Rash—Orlistat—type 2 diabetes mellitus	0.000142	0.000547	CcSEcCtD
Doxylamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000142	0.000546	CcSEcCtD
Doxylamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000141	0.000542	CcSEcCtD
Doxylamine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000541	CcSEcCtD
Doxylamine—Somnolence—Ramipril—type 2 diabetes mellitus	0.00014	0.000541	CcSEcCtD
Doxylamine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000139	0.000533	CcSEcCtD
Doxylamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000137	0.000529	CcSEcCtD
Doxylamine—Dizziness—Metformin—type 2 diabetes mellitus	0.000137	0.000528	CcSEcCtD
Doxylamine—Doxepin—HTR2C—type 2 diabetes mellitus	0.000137	0.0265	CrCbGaD
Doxylamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000136	0.000525	CcSEcCtD
Doxylamine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000136	0.000525	CcSEcCtD
Doxylamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000136	0.000523	CcSEcCtD
Doxylamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000135	0.000521	CcSEcCtD
Doxylamine—Constipation—Ramipril—type 2 diabetes mellitus	0.000135	0.00052	CcSEcCtD
Doxylamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000516	CcSEcCtD
Doxylamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000134	0.000515	CcSEcCtD
Doxylamine—Promazine—ADRA2A—type 2 diabetes mellitus	0.000132	0.0256	CrCbGaD
Doxylamine—Asthenia—Losartan—type 2 diabetes mellitus	0.000132	0.000509	CcSEcCtD
Doxylamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000132	0.000508	CcSEcCtD
Doxylamine—Rash—Metformin—type 2 diabetes mellitus	0.000131	0.000504	CcSEcCtD
Doxylamine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000131	0.000503	CcSEcCtD
Doxylamine—Pruritus—Losartan—type 2 diabetes mellitus	0.00013	0.000502	CcSEcCtD
Doxylamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00013	0.000501	CcSEcCtD
Doxylamine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000129	0.000499	CcSEcCtD
Doxylamine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000126	0.000485	CcSEcCtD
Doxylamine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000126	0.000483	CcSEcCtD
Doxylamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000125	0.000479	CcSEcCtD
Doxylamine—Rash—Irbesartan—type 2 diabetes mellitus	0.000123	0.000475	CcSEcCtD
Doxylamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000123	0.000475	CcSEcCtD
Doxylamine—Nausea—Metformin—type 2 diabetes mellitus	0.000123	0.000475	CcSEcCtD
Doxylamine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	0.000122	0.0236	CrCbGaD
Doxylamine—Promazine—HTR2C—type 2 diabetes mellitus	0.000122	0.0235	CrCbGaD
Doxylamine—Dizziness—Losartan—type 2 diabetes mellitus	0.000122	0.000469	CcSEcCtD
Doxylamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000117	0.000451	CcSEcCtD
Doxylamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000116	0.000448	CcSEcCtD
Doxylamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000448	CcSEcCtD
Doxylamine—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	0.000116	0.0224	CrCbGaD
Doxylamine—Rash—Losartan—type 2 diabetes mellitus	0.000116	0.000447	CcSEcCtD
Doxylamine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000116	0.000447	CcSEcCtD
Doxylamine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	0.000115	0.0222	CrCbGaD
Doxylamine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000113	0.000436	CcSEcCtD
Doxylamine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000112	0.00043	CcSEcCtD
Doxylamine—Nausea—Losartan—type 2 diabetes mellitus	0.000109	0.000421	CcSEcCtD
Doxylamine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	0.000109	0.0211	CrCbGaD
Doxylamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000108	0.000416	CcSEcCtD
Doxylamine—Imipramine—HTR2C—type 2 diabetes mellitus	0.000107	0.0206	CrCbGaD
Doxylamine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000107	0.0206	CrCbGaD
Doxylamine—Amitriptyline—HTR2C—type 2 diabetes mellitus	0.000106	0.0205	CrCbGaD
Doxylamine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000106	0.0205	CrCbGaD
Doxylamine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	0.000106	0.0205	CrCbGaD
Doxylamine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000104	0.000402	CcSEcCtD
Doxylamine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	0.000104	0.0201	CrCbGaD
Doxylamine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	0.000104	0.02	CrCbGaD
Doxylamine—Doxepin—CYP1A2—type 2 diabetes mellitus	0.000104	0.02	CrCbGaD
Doxylamine—Methadone—CYP1A2—type 2 diabetes mellitus	0.000103	0.0199	CrCbGaD
Doxylamine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	0.000101	0.0194	CrCbGaD
Doxylamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.0001	0.000387	CcSEcCtD
Doxylamine—Rash—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000384	CcSEcCtD
Doxylamine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000383	CcSEcCtD
Doxylamine—Nausea—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000361	CcSEcCtD
Doxylamine—Promazine—CYP1A2—type 2 diabetes mellitus	9.2e-05	0.0178	CrCbGaD
Doxylamine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	8.81e-05	0.017	CrCbGaD
Doxylamine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	8.74e-05	0.0169	CrCbGaD
Doxylamine—Imipramine—CYP2E1—type 2 diabetes mellitus	8.47e-05	0.0163	CrCbGaD
Doxylamine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	8.42e-05	0.0162	CrCbGaD
Doxylamine—Imipramine—CYP1A2—type 2 diabetes mellitus	8.06e-05	0.0155	CrCbGaD
Doxylamine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	8.01e-05	0.0154	CrCbGaD
Doxylamine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	6.88e-05	0.0133	CrCbGaD
Doxylamine—Doxepin—CYP3A4—type 2 diabetes mellitus	6.85e-05	0.0132	CrCbGaD
Doxylamine—Methadone—CYP3A4—type 2 diabetes mellitus	6.82e-05	0.0132	CrCbGaD
Doxylamine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	6.68e-05	0.0129	CrCbGaD
Doxylamine—Promazine—CYP3A4—type 2 diabetes mellitus	6.09e-05	0.0118	CrCbGaD
Doxylamine—Imipramine—CYP3A4—type 2 diabetes mellitus	5.33e-05	0.0103	CrCbGaD
Doxylamine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	5.3e-05	0.0102	CrCbGaD
Doxylamine—Amitriptyline—ALB—type 2 diabetes mellitus	4.62e-05	0.00892	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.36e-05	0.000969	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.35e-05	0.000966	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GIPR—type 2 diabetes mellitus	3.35e-05	0.000966	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.32e-05	0.000959	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	3.32e-05	0.000959	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.31e-05	0.000956	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—AGT—type 2 diabetes mellitus	3.31e-05	0.000955	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	3.25e-05	0.000936	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	3.24e-05	0.000933	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	3.23e-05	0.000931	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	3.22e-05	0.000928	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	3.17e-05	0.000914	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	3.16e-05	0.000911	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	3.15e-05	0.000909	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	3.14e-05	0.000906	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	3.14e-05	0.000905	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	3.13e-05	0.000902	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	3.07e-05	0.000886	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	3.07e-05	0.000886	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MC4R—type 2 diabetes mellitus	3.06e-05	0.000884	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	3.06e-05	0.000883	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	3.06e-05	0.000882	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	3.05e-05	0.000879	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	3.02e-05	0.000871	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	3.02e-05	0.000871	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	3.01e-05	0.000869	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	3.01e-05	0.000868	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.96e-05	0.000853	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.95e-05	0.000851	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.93e-05	0.000845	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.92e-05	0.000842	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.85e-05	0.000822	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.84e-05	0.00082	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.81e-05	0.000811	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.8e-05	0.000809	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.8e-05	0.000808	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.8e-05	0.000807	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.8e-05	0.000806	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.79e-05	0.000805	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.79e-05	0.000804	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.78e-05	0.000802	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.78e-05	0.000801	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.77e-05	0.000799	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.75e-05	0.000794	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.74e-05	0.000791	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.74e-05	0.000791	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.74e-05	0.000789	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.73e-05	0.000789	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.73e-05	0.000787	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.69e-05	0.000775	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.68e-05	0.000772	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.61e-05	0.000754	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.6e-05	0.000751	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.54e-05	0.000733	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.53e-05	0.00073	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.51e-05	0.000725	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.51e-05	0.000723	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.5e-05	0.000721	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.49e-05	0.000719	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.43e-05	0.000701	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.42e-05	0.000698	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.41e-05	0.000695	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.4e-05	0.000693	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.38e-05	0.000686	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.37e-05	0.000684	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.27e-05	0.000654	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.26e-05	0.000653	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.26e-05	0.000651	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.24e-05	0.000647	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.23e-05	0.000645	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.22e-05	0.000641	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.22e-05	0.000641	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.21e-05	0.000639	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.21e-05	0.000639	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.19e-05	0.000632	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.18e-05	0.00063	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.16e-05	0.000625	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.16e-05	0.000625	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.16e-05	0.000623	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.16e-05	0.000623	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.16e-05	0.000623	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.16e-05	0.000623	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	2.16e-05	0.000622	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.15e-05	0.000621	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.15e-05	0.000621	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.15e-05	0.00062	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	2.15e-05	0.00062	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.14e-05	0.000618	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.13e-05	0.000614	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.12e-05	0.000612	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.05e-05	0.000593	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.05e-05	0.000591	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.02e-05	0.000583	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.02e-05	0.000582	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.98e-05	0.00057	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.97e-05	0.000568	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.95e-05	0.000563	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.95e-05	0.000561	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.93e-05	0.000557	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.92e-05	0.000555	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.92e-05	0.000553	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.91e-05	0.000551	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.91e-05	0.00055	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.9e-05	0.000548	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.88e-05	0.000542	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.87e-05	0.00054	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.87e-05	0.00054	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.87e-05	0.00054	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.87e-05	0.000538	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.86e-05	0.000538	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.86e-05	0.000537	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.86e-05	0.000535	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.84e-05	0.00053	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.83e-05	0.000528	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.79e-05	0.000518	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.79e-05	0.000516	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.78e-05	0.000514	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.78e-05	0.000513	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.74e-05	0.000501	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.73e-05	0.000499	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.73e-05	0.000499	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.73e-05	0.000499	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.73e-05	0.000498	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.73e-05	0.000498	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.71e-05	0.000492	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.7e-05	0.00049	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.68e-05	0.000486	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.68e-05	0.000484	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.68e-05	0.000484	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.68e-05	0.000484	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.67e-05	0.000482	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.67e-05	0.000482	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.65e-05	0.000475	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.64e-05	0.000474	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.64e-05	0.000473	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.64e-05	0.000473	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.64e-05	0.000472	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.64e-05	0.000472	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.62e-05	0.000468	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.62e-05	0.000466	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.58e-05	0.000455	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.57e-05	0.000453	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.53e-05	0.00044	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.52e-05	0.000439	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.52e-05	0.000438	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.51e-05	0.000437	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.5e-05	0.000433	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.5e-05	0.000433	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.5e-05	0.000431	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.5e-05	0.000431	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.48e-05	0.000426	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.47e-05	0.000425	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.47e-05	0.000425	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.47e-05	0.000423	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.4e-05	0.000405	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.4e-05	0.000404	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.38e-05	0.000398	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.38e-05	0.000398	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.38e-05	0.000397	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.37e-05	0.000396	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.31e-05	0.000377	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.3e-05	0.000375	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.29e-05	0.000373	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.29e-05	0.000372	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.28e-05	0.000368	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.28e-05	0.000368	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.27e-05	0.000367	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.27e-05	0.000367	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.27e-05	0.000366	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.27e-05	0.000365	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.26e-05	0.000365	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.26e-05	0.000364	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.25e-05	0.000361	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.25e-05	0.00036	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.23e-05	0.000356	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.23e-05	0.000355	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.23e-05	0.000354	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.22e-05	0.000353	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.21e-05	0.00035	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.21e-05	0.000349	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.18e-05	0.00034	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.17e-05	0.000339	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.15e-05	0.000333	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.15e-05	0.000331	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.1e-05	0.000319	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.1e-05	0.000318	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.08e-05	0.000313	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.08e-05	0.000312	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	1.06e-05	0.000306	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.06e-05	0.000305	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.01e-05	0.000292	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.01e-05	0.000291	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.01e-05	0.000291	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.01e-05	0.000291	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.01e-05	0.00029	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1e-05	0.00029	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.9e-06	0.000286	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.87e-06	0.000285	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.87e-06	0.000285	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.87e-06	0.000285	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.84e-06	0.000284	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.84e-06	0.000284	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.76e-06	0.000281	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.73e-06	0.000281	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.31e-06	0.000269	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.28e-06	0.000268	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.8e-06	0.000254	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.78e-06	0.000253	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	8.43e-06	0.000243	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	8.4e-06	0.000242	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.3e-06	0.000239	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.27e-06	0.000239	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.16e-06	0.000235	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.15e-06	0.000235	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.13e-06	0.000235	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.12e-06	0.000234	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.12e-06	0.000234	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.09e-06	0.000233	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.75e-06	0.000223	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.72e-06	0.000223	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.39e-06	0.000213	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.39e-06	0.000213	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.37e-06	0.000213	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.37e-06	0.000213	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.96e-06	0.000201	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.94e-06	0.0002	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.34e-06	0.000183	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.32e-06	0.000182	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.28e-06	0.000181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.26e-06	0.000181	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.24e-06	0.00018	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.22e-06	0.000179	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.93e-06	0.000171	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.91e-06	0.000171	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.87e-06	0.000169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.85e-06	0.000169	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.75e-06	0.000166	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.74e-06	0.000165	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.47e-06	0.000158	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.45e-06	0.000157	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.33e-06	0.000154	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.31e-06	0.000153	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.89e-06	0.000141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.87e-06	0.000141	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.79e-06	0.000138	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.78e-06	0.000138	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.68e-06	0.000106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.67e-06	0.000106	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.4e-06	9.81e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.39e-06	9.77e-05	CbGpPWpGaD
